Education
About Us
Working with TipRanks
Follow Us
Mirion Technologies (MIR)
NYSE:MIR
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.11Last Year’s EPS
0.1Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 29, 2025
|% Change Since: 12.36%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Positive
Mirion Technologies demonstrated strong financial and operational performance in Q1 2025, with significant growth in revenue, orders, and adjusted EPS. The acquisition of Oncospace and the nuclear power segment's robust growth are notable positives. However, challenges remain in the medical segment and tariff impacts, particularly concerning China. Despite these challenges, the company's strategic initiatives and market opportunities position it well for future growth.Company Guidance
During the Mirion Technologies First Quarter 2025 Earnings Conference Call, the company reported robust financial and operational performance. Key metrics included a 6% organic revenue growth and an 18.2% increase in adjusted EBITDA to $47 million, with margins rising by 260 basis points to 23.1%. The company also achieved an 11.5% growth in first-quarter orders, largely driven by nuclear power orders, and reported an adjusted free cash flow of $29 million, with a 62% conversion of adjusted EBITDA. Additionally, Mirion repurchased 1.2 million shares for $18.6 million. The company reaffirmed its full-year 2025 guidance for organic revenue growth, adjusted EBITDA, adjusted EPS, and adjusted free cash flow, while slightly adjusting revenue growth expectations upwards to account for favorable foreign exchange rates.Strong Start to Fiscal Year 2025
Mirion Technologies reported a 6% organic revenue growth in Q1 2025, with adjusted EBITDA totaling $47 million, which is an 18.2% increase from last year. Adjusted EPS grew by 67% to $0.10 per share.
Significant Order Growth
The company experienced an 11.5% increase in orders, driven largely by nuclear power orders, marking the best first quarter performance since going public.
Acquisition of Oncospace
Mirion acquired Oncospace, a cloud-native data analytics platform, enhancing its cancer care portfolio despite the acquisition being small in initial revenue and adjusted EBITDA contribution.
Nuclear Power Segment Growth
Nuclear power revenue grew by 17.6%, supported by both the existing installed base and new builds, indicating a strong market momentum.
Positive Cash Flow and Share Repurchase
The company generated $29 million in adjusted free cash flow with a 62% conversion of adjusted EBITDA and repurchased 1.2 million shares for $18.6 million.
---
MIR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MIR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 29, 2025 | $15.62 | $15.78 | +1.02% |
Feb 11, 2025 | $16.17 | $16.36 | +1.18% |
Oct 29, 2024 | $14.07 | $14.75 | +4.83% |
Aug 01, 2024 | $10.30 | $10.09 | -2.04% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Mirion Technologies (MIR) report earnings?
Mirion Technologies (MIR) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Mirion Technologies (MIR) earnings time?
Mirion Technologies (MIR) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MIR EPS forecast?
MIR EPS forecast for the fiscal quarter 2025 (Q2) is 0.11.
---